Merck KGaA's stock remains a 'hold' due to its high valuation, trading at an earnings multiple of around 20 and a 4.5% free ...
Merck KGa A officials say that, ultimately, the SMARTfacturing transformation benefits its customers, patients, and the ...
XTRA:MRK Earnings and Revenue History March 14th 2025 How Do Unusual Items Influence Profit? For anyone who wants to understand Merck KGaA's profit beyond the statutory numbers, i ...
Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...
Clinical Trials Arena on MSN22h
Immunovant will not seek approval for MG therapy, despite hitting endpointsImmunovant will use results from its Phase III myasthenia gravis study to support pipeline candidate IMVT-1402 over the trial ...
Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions: Our Bureau, Bengaluru Thursday, March 20, 2025, 14:15 Hrs [IST] Syngene International ...
Switzerland-headquartered iOnctura today announced the appointments of Elizabeth Holt as chief business officer (CBO) and Dr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback